Century Therapeutics Stock Forecast

IPSC's stock price has decreased by -63.5% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Century Therapeutics stock have an average target of 3.00, with a low estimate of 2.00 and a high estimate of 6.00. The average target predicts an increase of 470.78% from the current stock price of 0.53.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$2.00	$3.00	$2.00	$6.00
Change	+280.52%	+470.78%	+280.52%	+1041.6%

Analyst Ratings

The average analyst rating for Century Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	4	4	4	4	4	4
Buy	1	1	1	1	1	1
Hold	0	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Daina Graybosch Leerink Partners	Leerink Partners	Buy → Hold Downgrades $7 → $2	Buy → Hold	Downgrades	$7 → $2	+280.52%	Nov 17, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $7 → $6	Strong Buy	Maintains	$7 → $6	+1,041.55%	May 16, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $5 → $2	Strong Buy	Maintains	$5 → $2	+280.52%	Apr 3, 2025
Kelsey Goodwin Guggenheim	Guggenheim	Strong Buy Reiterates n/a	Strong Buy	Reiterates	n/a	n/a	Mar 28, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $11 → $7	Strong Buy	Maintains	$11 → $7	+1,231.81%	Mar 24, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

111.36M

from 6.59M

1,590.09%

from 6.59M

Revenue Next Year

n/a

from 111.36M

EPS This Year

-0.14

from -1.61

EPS Next Year

-0.88

from -0.14

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	5.20M	2.24M	6.59M	111.36M	-
Revenue Growth	-	-	-	-57.01%	194.81%	1,590.09%	-
EPS	-7.16	-2.96	-2.27	-2.30	-1.61	-0.14	-0.88
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	114.7M	n/a
Avg	111.4M	n/a
Low	107.0M	n/a

Revenue Growth

Revenue Growth	2025	2026
High	1,640.2%	-
Avg	1,590.1%	-
Low	1,523.6%	-

EPS Forecast

EPS	2025	2026
High	-0.14	-0.86
Avg	-0.14	-0.88
Low	-0.14	-0.88

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.